tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JAZZ Stock Latest News

Avadel says court requires 3.85% of Lumryz sales go to Jazz
The FlyAvadel says court requires 3.85% of Lumryz sales go to Jazz
1d ago
AVDL
JAZZ
Jazz Pharmaceuticals’ ZW25 Study Update: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Jazz Pharmaceuticals’ ZW25 Study Update: A Potential Game-Changer in Cancer Treatment
6d ago
JAZZ
Jazz Pharmaceuticals’ Modeyso recommended for glioma by NCCN Guidelines
PremiumThe Fly
Jazz Pharmaceuticals’ Modeyso recommended for glioma by NCCN Guidelines
9d ago
JAZZ
Kohl’s, Bill.com, Novavax, Jazz, Nvidia: Trending by Analysts
PremiumWeekend Updates
Kohl’s, Bill.com, Novavax, Jazz, Nvidia: Trending by Analysts
19d ago
KSS
BILL
Jazz Pharmaceuticals’ Pregnancy Study on Epidiolex: Key Insights for Investors
PremiumCompany Announcements
Jazz Pharmaceuticals’ Pregnancy Study on Epidiolex: Key Insights for Investors
20d ago
JAZZ
Jazz Pharmaceuticals price target raised to $205 from $200 at Truist
PremiumThe FlyJazz Pharmaceuticals price target raised to $205 from $200 at Truist
21d ago
JAZZ
Jazz Pharmaceuticals price target raised to $151 from $145 at RBC Capital
Premium
The Fly
Jazz Pharmaceuticals price target raised to $151 from $145 at RBC Capital
21d ago
JAZZ
Jazz Pharmaceuticals price target raised to $163 from $162 at Morgan Stanley
Premium
The Fly
Jazz Pharmaceuticals price target raised to $163 from $162 at Morgan Stanley
21d ago
JAZZ
Optimistic Buy Rating for Jazz Pharmaceuticals Driven by Strategic Launch of Modeyso and Advancements in Global Phase 3 Study
PremiumRatings
Optimistic Buy Rating for Jazz Pharmaceuticals Driven by Strategic Launch of Modeyso and Advancements in Global Phase 3 Study
21d ago
JAZZ
Jazz Pharmaceuticals Advances Study on Epidyolex® for Seizure Disorders
PremiumCompany Announcements
Jazz Pharmaceuticals Advances Study on Epidyolex® for Seizure Disorders
22d ago
JAZZ
Jazz Pharmaceuticals’ Zanidatamab Study: A New Hope for Metastatic Breast Cancer?
PremiumCompany Announcements
Jazz Pharmaceuticals’ Zanidatamab Study: A New Hope for Metastatic Breast Cancer?
24d ago
JAZZ
Jazz Pharmaceuticals Advances in HER2-positive Biliary Tract Cancer Treatment
PremiumCompany Announcements
Jazz Pharmaceuticals Advances in HER2-positive Biliary Tract Cancer Treatment
25d ago
JAZZ
Jazz Pharmaceuticals Advances in HER2-positive Biliary Tract Cancer Treatment
PremiumCompany AnnouncementsJazz Pharmaceuticals Advances in HER2-positive Biliary Tract Cancer Treatment
27d ago
JAZZ
Jazz Pharmaceuticals’ Zanidatamab Study: A New Hope for HER2-positive Biliary Tract Cancer?
Premium
Company Announcements
Jazz Pharmaceuticals’ Zanidatamab Study: A New Hope for HER2-positive Biliary Tract Cancer?
29d ago
JAZZ
Jazz Pharmaceuticals and Saniona announce global license agreement
Premium
The Fly
Jazz Pharmaceuticals and Saniona announce global license agreement
29d ago
JAZZ
Jazz Pharmaceuticals price target raised to $225 from $217 at BofA
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $225 from $217 at BofA
1M ago
JAZZ
Promising Market Potential for Jazz Pharmaceuticals’ Modeyso Drives Buy Rating
PremiumRatings
Promising Market Potential for Jazz Pharmaceuticals’ Modeyso Drives Buy Rating
1M ago
JAZZ
Jazz Pharmaceuticals’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Jazz Pharmaceuticals’ Earnings Call: Growth Amid Challenges
1M ago
JAZZ
Jazz Pharmaceuticals confirms FDA approval of Modeyso
PremiumThe Fly
Jazz Pharmaceuticals confirms FDA approval of Modeyso
1M ago
JAZZ
Jazz Pharmaceuticals wins accelerated FDA approval of dordaviprone
PremiumThe FlyJazz Pharmaceuticals wins accelerated FDA approval of dordaviprone
1M ago
JAZZ
Positive Growth Outlook for Jazz Pharmaceuticals Amid Strategic Developments and Promising Drug Pipeline
Premium
Ratings
Positive Growth Outlook for Jazz Pharmaceuticals Amid Strategic Developments and Promising Drug Pipeline
1M ago
JAZZ
Jazz Pharmaceuticals price target lowered to $200 from $230 at Truist
Premium
The Fly
Jazz Pharmaceuticals price target lowered to $200 from $230 at Truist
1M ago
JAZZ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >